Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lee Han Myung — Century Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Lee Han Myung

Lee Han Myung

Director at Century Therapeutics, Inc. · on record since Jun 12, 2026

Insider trading activity of Lee Han Myung

Transactions on record: 2; since Dec 11, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where Lee Han Myung has traded

Century Therapeutics, Inc.2 tx · Jun 12, 2026

Track record of Lee Han Myung

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lee Han Myung

Co-insiders of Lee Han Myung

BAYER AKTIENGESELLSCHAFTCentury Therapeutics, Inc.
Bayer World Investments B.V.Century Therapeutics, Inc.
Blackwell KimberlyCentury Therapeutics, Inc.
Borges LuisCentury Therapeutics, Inc.
BUTITTA CYNTHIA MCentury Therapeutics, Inc.
Carlo RizzutoCentury Therapeutics, Inc.
Carr DouglasCentury Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Casdin EliCentury Therapeutics, Inc.

Conn MorganCentury Therapeutics, Inc.

Cowan ChadCentury Therapeutics, Inc.

Diem Michael CraigCentury Therapeutics, Inc.

Farid AdrienneCentury Therapeutics, Inc.

Flores OsvaldoCentury Therapeutics, Inc.

FUJIFILM Cellular Dynamics, Inc.Century Therapeutics, Inc.

FUJIFILM CorpCentury Therapeutics, Inc.

FUJIFILM Holdings America CorpCentury Therapeutics, Inc.

FUJIFILM Holdings CorpCentury Therapeutics, Inc.

JIMENEZ JOSEPHCentury Therapeutics, Inc.

Levitsky HyamCentury Therapeutics, Inc.

Murphy Martin PatrickCentury Therapeutics, Inc.

Pfeiffenberger BrentCentury Therapeutics, Inc.

Quimi DaphneCentury Therapeutics, Inc.

Riva AlessandroCentury Therapeutics, Inc.

Russotti GregoryCentury Therapeutics, Inc.

Versant Vantage II GP-GP, LLCCentury Therapeutics, Inc.

Versant Vantage II GP, L.P.Century Therapeutics, Inc.

Versant Vantage II, L.P.Century Therapeutics, Inc.

Versant Venture Capital VI, L.P.Century Therapeutics, Inc.

Versant Ventures VI GP-GP, LLCCentury Therapeutics, Inc.

Versant Ventures VI GP, L.P.Century Therapeutics, Inc.

Walbert Timothy PCentury Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Century Therapeutics, Inc.	Jun 12, 2026	AwardD	74,000	0.00 USD	$0	SEC
Century Therapeutics, Inc.	Dec 11, 2025	AwardD	88,000	0.00 USD	$0	SEC